301650.001(BF) 1Consulting Agreement • December 12th, 1996 • Cheung Laboratories Inc • Electromedical & electrotherapeutic apparatus • Illinois
SERIES B WARRANT TO PURCHASE SHARES OF COMMON STOCK IMUNON, INC.Imunon, Inc. • February 9th, 2024 • Pharmaceutical preparations
THIS SERIES B WARRANT TO PURCHASE SHARES OF COMMON STOCK (this “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Original Issuance Date (the “Initial Exercise Date”) and on or prior to 5:00 pm (New York City time) on [*] __, 2025[1] (the “Termination Date”) but not thereafter, to subscribe for and purchase from IMUNON, INC., a Delaware corporation (the “Company”), up to ______ shares of Common Stock, par value $0.01 per share (the “Common Stock”), of the Company (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Exhibit 10.1 ------------ EXECUTIVE EMPLOYMENT AGREEMENT ------------------------------ EMPLOYMENT AGREEMENT, made as of the 14th day of January, 2000, by and between Spencer J. Volk (the "Executive"), an individual residing at c/o Celsion...Employment Agreement • February 24th, 2000 • Celsion Corp • Electromedical & electrotherapeutic apparatus
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 3rd, 2020 • Celsion CORP • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February 27, 2020, between Celsion Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
andRights Agreement • August 21st, 2002 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Delaware
EXHIBIT 10.9 LICENSE AGREEMENT THIS AGREEMENT made and entered into as of the tenth day of November, 1999 (this "AGREEMENT"), by and between DUKE UNIVERSITY, a North Carolina not-for-profit corporation organized under the laws of North Carolina (the...License Agreement • December 29th, 1999 • Celsion Corp • Electromedical & electrotherapeutic apparatus • North Carolina
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT, effective as of the 8th day of June, 2000, by and between John Mon (the "Executive"), an individual residing at c/o Celsion Corporation, 10220-1 Old...Executive Employment Agreement • December 30th, 2002 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
AMENDMENT NO. 1 TO RIGHTS AGREEMENT DATED AS OF AUGUST 15, 2002Rights Agreement • June 14th, 2004 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Delaware
EXHIBIT 10.24 SERVICE AGREEMENT ----------------- This Agreement, made and entered into this 20th day of September 2000, between the British Columbia Cancer Agency, Division of Medical Oncology, Investigational Drug Section's ProPharma Pharmaceutical...Service Agreement • December 28th, 2000 • Celsion Corp • Electromedical & electrotherapeutic apparatus • British Columbia
WITNESSETH:Employment Agreement • December 28th, 2001 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
EXECUTIVE EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT, effective as of January 15, 2002, by and between DR. WILLIAM E. GANNON, JR.(the "Executive"), an individual residing at 515 5th Street, N.E., Washington, D.C. 2002, and CELSION CORPORATION (the...Employment Agreement • December 30th, 2002 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (the "Agreement") is made by Cheung Laboratories, Inc., a Maryland corporation (the "Company"), for the benefit of the undersigned investor ("Investor", collectively, the "Investors")....Registration Rights Agreement • January 13th, 1999 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
EXHIBIT 10.21 EXECUTIVE EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT, made as of the 8th day of June, 2000, by and between John Mon (the "Executive"), an individual residing at c/o Celsion Corporation, 10220-1 Old Columbia Road, Columbia, Maryland...Employment Agreement • December 28th, 2000 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
EXHIBIT 4.14 CONSULTING AGREEMENT -------------------- THIS CONSULTING AGREEMENT (this "Agreement") is made and entered into by and between CELSION CORPORATION, a Delaware Corporation, which has an address of 10220-I Old Columbia Road, Columbia,...Consulting Agreement • June 14th, 2004 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
EXHIBIT 10.24 ADVISORY AGREEMENT THIS ADVISORY AGREEMENT (the "Agreement") is effective as of the 18th day of May, 2001, by and between CELSION CORPORATION, a Delaware corporation (the "Company"), and DR. KRIS VENKAT ("Venkat"), and SUNDARI...Advisory Agreement • December 28th, 2001 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
AGREEMENT ---------Agreement • August 28th, 2003 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
EXHIBIT 10.22 EXECUTIVE EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT, made as of the ____ day of May, 2000, by and between Dennis Smith (the "Executive"), an individual residing at 4818 Lancashire Lane, Tallahassee, Florida 32308, and Celsion Corporation...Employment Agreement • December 28th, 2000 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
EXHIBIT 4.5 April 8, 2003 Mr. Anthony Deasey Executive Vice President Finance and Administration Chief Financial Officer CELSION CORPORATION 10220-I Old Columbia Road Columbia, MD 21046 Dear Tony: This letter will serve as an agreement between Celsion...Celsion Corp • August 28th, 2003 • Electromedical & electrotherapeutic apparatus • Maryland
REPRESENTATIVE’S COMMON STOCK PURCHASE WARRANTCelsion CORP • October 31st, 2017 • Pharmaceutical preparations
THIS REPRESENTATIVE’S COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [ ] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [ ], 2018 (the “Initial Exercise Date”) and on or prior to the close of business on [ ] (the “Termination Date”), provided, however, that if such date is not a Trading Day, the Termination Date shall be the immediately following Trading Day, but not thereafter, to subscribe for and purchase from Celsion Corporation, a Delaware corporation (the “Company”), up to [ ] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (this "Agreement") is made and entered into by and between CELSION CORPORATION, a Delaware Corporation, which has an address of 10220-L Old Columbia Road, Columbia, MD 21046-1705 ("Celsion"), and Dr....Consulting Agreement • May 26th, 2004 • Celsion Corp • Electromedical & electrotherapeutic apparatus
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 13th, 2017 • Celsion CORP • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February __, 2017, between Celsion Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
M.H. MEYERSON & CO., INC. FOUNDED 1960 BROKER & DEALER IN SECURITIES UNDERWRITERSAgreement • July 6th, 2001 • Celsion Corp • Electromedical & electrotherapeutic apparatus • New Jersey
EXHIBIT 10.1 LICENSE AGREEMENT THIS AGREEMENT made and entered into this eighteenth day of July, 2003, by and between DUKE UNIVERSITY, a North Carolina corporation not-for-profit, (hereinafter called the "LICENSOR"), having its principal office at...License Agreement • August 28th, 2003 • Celsion Corp • Electromedical & electrotherapeutic apparatus • North Carolina
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 7th, 2022 • Celsion CORP • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April 6, 2022, between Celsion Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
CELSION CORPORATION Shares of Common Stock (par value $0.01 per share) At The Market Offering AgreementCelsion CORP • May 25th, 2022 • Pharmaceutical preparations • New York
Celsion Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (the “Agent”), as follows:
WITNESSETH:Employment Agreement • December 14th, 2000 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 29th, 2015 • Celsion CORP • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of May 27, 2015 between Celsion Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
FORM OF SERIES A COMMON STOCK PURCHASE WARRANT celsion corporationCelsion CORP • January 21st, 2014 • Pharmaceutical preparations
THIS SERIES A COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January __, 2014 (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Celsion Corporation, a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
EXHIBIT 10.23 OPTION AGREEMENT ---------------- This AGREEMENT is made this 8th day of August, 2000, between Duke University (hereinafter referred to as "University"), a university having an office at Durham, North Carolina, and Celsion Corporation...Option Agreement • December 28th, 2000 • Celsion Corp • Electromedical & electrotherapeutic apparatus • North Carolina
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 9th, 2024 • Imunon, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of [•], 2024, between Imunon, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
COMMON STOCK PURCHASE WARRANT CELSION CORPORATIONCelsion CORP • July 6th, 2011 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Celsion Corporation, a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
CHEUNG LABORATORIES, INC. PATENT LICENSE AGREEMENT M.I.T.'S OFFER TO CHEUNG LABORATORIES, INC. TO ENTER INTO THIS LICENSE AGREEMENT SHALL EXTEND UNTIL NO LATER THAN JUNE 1, 1996. (EXCLUSIVE) 319999.001(B&F) 2 TABLE OF CONTENTS...Patent License Agreement • December 12th, 1996 • Cheung Laboratories Inc • Electromedical & electrotherapeutic apparatus • Massachusetts
PURCHASE AGREEMENTPurchase Agreement • September 8th, 2020 • Celsion CORP • Pharmaceutical preparations • Illinois
THIS PURCHASE AGREEMENT (the “Agreement”), dated as of September 8, 2020, by and between CELSION CORPORATION, a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”). Capitalized terms used herein and not otherwise defined herein are defined in Section 1 hereof.
PRE-FUNDED WARRANT TO PURCHASE SHARES OF COMMON STOCK IMUNON, INC.Imunon, Inc. • January 18th, 2024 • Pharmaceutical preparations
THIS PRE-FUNDED WARRANT TO PURCHASE SHARES OF COMMON STOCK (this “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from IMUNON, INC., a Delaware corporation (the “Company”), up to ______ shares of Common Stock, par value $0.01 per share (the “Common Stock”), of the Company (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
BETWEENTransaction Agreement • January 22nd, 2003 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Delaware
